USE OF GESTAGENS IN COMBINATION WITH (6S) 5-METHYTETEHYDROPHOLATE FOR ENDOMETRIOSIS THERAPY WITH SIMULTANEOUS REDUCTION OF THERAPY SIDE EFFECTS AS WELL AS THE RISK REDUCTION OF CONGENITAL MALFORMATION IN THE CASE OF PREGNANCY.
CHRISTIAN SEITZ,ANNEMARIE WASSERFALL,KONSTANZE DIEFENBACH,KRISTINA KING,HOLGER ZIMMERMANN
申请号：
BRPI0815756
公开号：
BRPI0815756A2
申请日:
2008.07.30
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
Use of gestagen in combination with (6S)-5-methyltetrahydrofolate for the production of a pharmaceutical preparation (I) for the therapy of endometriosis with simultaneous reduction of therapy side-effects, preferably negative effects on bone density or bone metabolism, osteoporosis risk, risk of congenital malformations and pregnancy complications in early stage of pregnancy, is claimed, where the daily dose of the gestagen corresponds to at least an ovulation inhibiting dose to maximally dual of the ovulation inhibiting dose. ACTIVITY : Gynecological； Osteopathic. MECHANISM OF ACTION : None given.
